Tymlos, illustration of injection pen form (not a photo of the actual pack)

Illustrative image.

Tymlos

Abaloparatide

Prescription required

$5250.00

80mcg/dose · 3 × 1 pre-filled pen · 3 months supply

BrandBranded medicine

$1750.00 per month

How long a supply?

1 month$1750.00 a month
3 months$1750.00 a month
6 months$1750.00 a month
Supplied from UK

Test mode: no payment is taken. View cart

Annual cost

$21000a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About Tymlos

Overview

Tymlos is a prescription medicine containing abaloparatide, given as an injection under the skin using a pre-filled pen. It treats osteoporosis in postmenopausal women and is used to increase bone density in men with osteoporosis who are at high risk of fracture or have not responded to, or cannot tolerate, other available osteoporosis treatments. It works by stimulating bone-building cells to form new bone.

What it treats

- Osteoporosis in postmenopausal women at high risk of fracture, or when other available osteoporosis treatments have failed or cannot be tolerated. - Osteoporosis in men at high risk of fracture, or when other available osteoporosis treatments have failed or cannot be tolerated, to increase bone density.

Safety information

Side effects

Common side effects reported in postmenopausal women include increased calcium in the urine, dizziness, nausea, headache, a pounding or racing heartbeat, tiredness, upper abdominal pain and a spinning sensation (vertigo). In men, common side effects include redness, swelling or pain at the injection site, dizziness, joint pain, bruising, nausea, diarrhoea, bloating, abdominal pain and bone pain. Serious reactions include severe allergic reactions, including anaphylaxis, swelling beneath the skin (angioedema) and hives. Stop Tymlos and seek immediate medical help if an allergic reaction occurs. A severe allergic reaction requires permanent discontinuation. Other important risks include a drop in blood pressure when standing, high blood calcium, increased calcium in the urine and kidney stones. Contact your doctor if symptoms develop after an injection; sit or lie down if you experience symptoms of low blood pressure. The label also warns about osteosarcoma, a type of bone cancer. Tymlos should be avoided in people at increased risk, including those whose bones are still growing, those with certain bone diseases such as Paget’s disease, cancer involving the bones or a history of skeletal cancer, previous radiation treatment involving the skeleton, or inherited conditions that increase this risk. Tell your doctor if any of these apply.

When to call your doctor

• Get medical help immediately for signs of an allergic reaction, such as trouble breathing, swelling of the face, lips, tongue or throat, or hives (raised, itchy welts).

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not use Tymlos if you have had a severe allergic reaction to abaloparatide or any of its inactive ingredients. Reported reactions include anaphylaxis, swelling under the skin, difficulty breathing and hives. Stop treatment if an allergic reaction occurs. Tymlos must be stopped permanently after a severe allergic reaction. Tymlos should be avoided in people at increased risk of osteosarcoma (a type of bone cancer), including those with: • Growth plates that have not yet closed. • Metabolic bone diseases, including Paget’s disease. • Cancer that has spread to the bones or a history of bone cancer. • Previous external-beam or implant radiation therapy involving the bones. • Inherited disorders that increase the risk of osteosarcoma. It should also be avoided in people with high blood calcium or an underlying condition that causes it, such as primary hyperparathyroidism. Tymlos can cause a drop in blood pressure on standing. Sit or lie down if symptoms develop after an injection. Urine calcium should be monitored if high urine calcium or current urinary tract stones are suspected.

Interactions

No specific drug–drug interaction studies have been performed with Tymlos.

Using Tymlos

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store in the original carton to protect it from light. Check the pack for whether it must be refrigerated before first use and how long it may be kept at room temperature afterwards. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label TYMLOS (ABALOPARATIDE) INJECTION, SOLUTION [RADIUS HEALTH, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines